Company intelligence / Profile preview

Oto

London, England, United Kingdomjoinoto.com ↗

Ownership: Private
Development stage: Commercial

Overview

Oto offers a clinically validated digital program for tinnitus management based on cognitive behavioural therapy (CBT). Clinical studies and user data report that over 86% of users feel better within one month. The company has launched a fully remote clinical trial with Lindus Health to further validate its efficacy compared to therapist-delivered CBT.

Therapeutic areas: Neurology
Modalities: Non-pharmacological therapyDevice
Industry: Digital Health Medical Devices

Partnerships

Lindus HealthCambridge University researchers

Beyond the preview

Go deeper on Oto.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oto.

Explore the full profile